Walmart, CVS Facing Claims Over Recalled Blood Pressure Drug (1)

Oct. 4, 2018, 6:17 PMUpdated: Oct. 4, 2018, 6:36 PM

Wal-Mart Stores, Inc., CVS Health Co. and other retailers face a new proposed class suit in the wake of a recall of generic blood pressure medication tainted with a cancer-causing substance that plaintiffs allege was once used in the production of rocket fuel.

The Food and Drug Administration announced a voluntary recall in July of several brands of generic drugs that used valsartan supplied by a Chinese company, Zhejiang Hauhai Pharmaceuticals.

At that time, the FDA found N-nitrosodimethylamine, also known as NDMA, in the recalled valsartan products.

NDMA can cause liver damage and cancer in humans, the suit says.

Plaintiffs ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.